Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 37, Issue 5, 2006, Pages 970-974

  Kumala, Widyasari ^a   Rani, Aziz ^b  

^a TRISAKTI UNIVERSITY   (Indonesia)

^b CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751558604     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Achmad H. Pola uji resistensi in vitro isolat Helicobacter pylori daerah Malang terhadap antibiotik (In vitro resistance pattern against antibiotic in Malang). Malang, Indonesia. Pharos Bull 1996; 3: 3-7 (In Indonesian).
2. Berger SA, Gorea A, Moskowitz M, et al. Effect of inoculum size on antimicrobial susceptibility of Helicobacter pylori, Eur I Clin Microbiol Infect Dis 1993; 12: 782-3.
3. Birac C, Bouchard S, Camou C, et al. Six years follow-up of resistance to antibiotics of Helicobacter pylori in Bordeaux, France.Gut 1999 ;45(suppl 3): A107.
4. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Research 1995; 55: 562-5.
5. Boyanova L, Mentis A, Gubina M, et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 2002; 8: 388-96.
6. th ed. Approved Standard M2-A8. Wayne, PA: CLSI/NCCLS, 2005.
7. Croom KF, Goa KL. Levofloxacin: a review of its use in the treatment of bacterial infections in United State. Drugs 2003; 63: 2769-802.
8. Francesco VD, Margiotta M, Zullo A, et al. Clarithromycin resistant genotypes and eradication of Helicobacter pylori. Ann Int Med 2006; 144: 94-100.
9. Hartzen SH, Andersen LP, Bremmelgaard A, Colding H, Arpi M, Kristiansen J. Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother 1997; 41: 2634-9.
10. Jenks PJ, Labigne A, Ferrero LR. Exposure to metronldazol in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice. Antimicrob Agents Chemother 1999; 43: 777-81.
11. Ketut M. Prevalensi Helicobacter pylori pada evaluasi histopatologik biopsy endos-kopl penderita gastritis kronik (Prevalence of Helicobacter pylori in gastric biopsies histopathology evaluation of chronic gastritis). Proceedings of the National Symposium Helicobacter pylori and Gastroduodenal disease. Denpasar Bali, 25 Mar 1995: 13-26.
12. Kumala W, Rahim A, Sudarmono P, Rani A. Motility indole urease as an alternative diagnostic method for identifying Helicobacter pylori. Indon J Gastroenterol Hepatol Dig Endosc 2001; 2: 5-7.
13. Kupiers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999; 13 (suppl 1): 3-11.
14. Kwon DH, Pena JA, Osato MS, et al. Frameshift mutations in rdxA and metronodazole resistance in North America Helicobacter pylori isolates. J Antimicrob Chemother 2000; 46: 793-6.
15. th Western Pacific Congress on Chemotherapy and Infectious Diseases. 1-4 Dec 1996: 187-90.
16. Loivukene K, Maaroos HI, Kolk H, et al. Prevalence of antibiotic resistant Helicobacter pylori isolates in Estonia during 1995-2000 in comparison to the consumption of antibiotics used intreatment regimens. Clin Microbiol infect 2002; 8: 598-603.
17. Marshall BJ. Helicobacter pylori. The etiologic agent for peptic ulcer. JAMA SEA 1996; 12: 28-30.
18. Matsumura M, Hikiba Y, Ogura K, et al. Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium. J Clin Microbiol 2001; 39: 691-5.
19. Megraud F, H. pylori antibiotic resistanc: prevalence, importance and avances in testing. GUT 2004; 53: 1374-84.
20. Mitchell HM. The epidemiology of Helicobacter pylori. Curr Top Microbiol Immunol 1999; 241: 11-30.
21. Paul R, Postius S, Melchers K, et al. Mutations of the Helicobacter pylori genes rdxA and pbp 1 cause resistance against metronidazole and amoxicillin. Antimicrob Agents Chemother 2001; 45: 962-5.
22. Perez AL, Kato M, Nakagawa S, et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 2002; 7: 306-9.
23. Quintana-Guzman EM, Arias-Echandi ML, Chaves SP, Davidovich-Rose H, Schosinsky-Neverman K. Helicobacter pylori: susceptibility to amoxycillin, erythromycin, tetracycline, ciprofloxacin, nitrofurantoin and metronidazole in Costa Rica. Rev Biomed 1998; 9: 92-6.
24. Rourke OK, Goodman KJ, Grazioplene M, Redlinger T, Day SR. Determinants of geographic variation in Helicobacter pylori infection among children on the US-Mexico border. Am J Epidemiol 2003; 158: 816-24.
25. Stamm WE, Stapleton AE. Approach to the patient with urinary tract infection. In: Gorbach St, Barlett JG, Blacklow NR, eds. Infectious dis eases. Philadelpia: Saunders Comp, 1998; 443-54.
26. Suate K, Suyasa GN. Helicobacter pylori: Aspek mikrobiologik dan pola kepekaannya terhadap antimikroba (Microbiology aspect and resistant pattern against antimicrobial agents). Proceedings of the National Symposium on Helicobacter pylori and Gastroduodenal Disease, Denpasar Bali, 25 Mar 1995: 13-26.
27. Thyagarajan SP, Ray P, Das BK, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from India patients: multicentric study. J Gastroenterol Hepatol 2003; 18: 1373-8.
28. Torres J, Camorlinga-Ponce M. Perez-Perez G, et al. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Clin Microbiol 2001; 9: 2677-80.
29. Walt RP. Metronidazole resistant Helicobacter pylori of questional clinical importance. Lancet 1996; 348: 489-90.
30. Wirtz M, Kleeff J, Swoboda S, et al. Moxifloxacin penetration into human gastrointestinal tissues. J Antimicrob Chemother 2004; 53: 875-7.
31. Wu H, Shi XD, Wang HT, et al. Resistsance of Helicobacter pylori to metronidazole, tetracycline and amoxicillin. J Antimicrob Chemother 2000; 46: 121-3.
32. Zeiler HJ, Grohe K. The in vitro and in vivo activity of ciprofloxacin. Eur J Clin Microbiob 1984; 3: 339-43.